ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Disproportionality analysis of adverse events associated with bimekizumab: a real-world study based on FDA Adverse Event Reporting System (FAERS) Database.

Xiaojuan Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.